.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

PROVENTIL Drug Profile

« Back to Dashboard
Proventil is a drug marketed by Schering and 3M and is included in six NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in PROVENTIL is albuterol. There are thirty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the albuterol profile page.

Summary for Tradename: PROVENTIL

Patents:2
Applicants:2
NDAs:6
Drug Prices: :see details
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
PROVENTIL
albuterol sulfate
SOLUTION;INHALATION019243-002Jan 14, 1987DISCNNo► subscribe► subscribe
Schering
PROVENTIL
albuterol sulfate
TABLET, EXTENDED RELEASE;ORAL019383-001Jul 13, 1987DISCNNo► subscribe► subscribe
Schering
PROVENTIL
albuterol sulfate
TABLET;ORAL017853-002May 7, 1982DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROVENTIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
PROVENTIL
albuterol sulfate
SOLUTION;INHALATION019243-001Jan 14, 19873,644,353► subscribe
Schering
PROVENTIL
albuterol sulfate
TABLET, EXTENDED RELEASE;ORAL019383-001Jul 13, 19873,644,353► subscribe
Schering
PROVENTIL
albuterol sulfate
SYRUP;ORAL018062-001Jan 19, 19834,499,108► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: PROVENTIL

Drugname Dosage Strength RLD Submissiondate
albuterol sulfateInhalation Aerosol 0.09 mg base per actuation Proventil HFA 5/20/2015
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc